Haemoglobinopathies: Integrated Biochemical and Molecular Diagnosis in 5243 Patients
Open Access
Abstract
Background: Haemoglobinopathies are among the most common monogenic disorders worldwide. Early identification of asymptomatic carriers through reliable screening and molecular diagnostics is crucial for prevention programmes, especially in high-prevalence regions such as Southern Italy. Methods: A total of 5243 individuals were analysed between 2013 and 2024 using both biochemical and genetic parameters. First-level screening included full blood count, iron status, and high-performance liquid chromatography (HPLC) for haemoglobin variant quantification. Molecular analyses were performed using next-generation sequencing (NGS) for the HBA1, HBA2, and HBB genes. Results: We identified 267 individuals (11.2%) as carriers of α-thalassaemia and 473 individuals (16.7%) as carriers of β-thalassaemia. Among them, 5 were compound heterozygotes and 3 homozygous for the α-3.7 deletion. A rare case of HbG Philadelphia in association with a triplicated α-gene was also observed. The most common β-globin mutations included c.118C>T (β039, 44%), IVS-I-110 (17.7%), IVS-I-6 (12.7%), and IVS-I-1 (12.3%). Among α-globin mutations, the most prevalent were -α3.7 (48%), α2 IVS1 -5nt (15.4%), -20.5 Kb (14.2%), and triplicated α (11%). In total, 18.7% of individuals were found to carry either α- or β-thalassaemia traits. Conclusion: Our findings highlight the limitations of traditional diagnostic methods—such as the osmotic fragility test—and the importance of integrating haematological, biochemical, and molecular data to accurately identify thalassaemia carriers. The variability of genotype–phenotype correlations, especially in the context of immigration and genetic diversity, underscores the need for comprehensive molecular analysis. We propose a three-step diagnostic algorithm combining first-level screening, iron status assessment, and NGS-based sequencing for inconclusive cases.Keywords
This publication has 17 references indexed in Scilit:
- Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021eClinicalMedicine, 2024
- Spectrum of hemoglobinopathies with hematological and biochemical profile: A five year experience from a tertiary care hospitalPakistan Journal of Medical Sciences, 2022
- Erratum: EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathiesEuropean Journal of Human Genetics, 2015
- The Impact of Migrations on the Health Services for Rare Diseases in Europe: The Example of Haemoglobin DisordersThe Scientific World Journal, 2013
- Incidence of β-thalassemia carrier on 1495 couples in preconceptional periodThe Journal of Maternal-Fetal & Neonatal Medicine, 2012
- Hemoglobins S and C Interfere with Actin Remodeling in Plasmodium falciparum –Infected ErythrocytesScience, 2011
- The significance of the hemoglobin A2 value in screening for hemoglobinopathiesClinical Biochemistry, 2009
- Incidence of haemoglobinopathies in various populations — The impact of immigrationClinical Biochemistry, 2009
- Effect of HbS in the determination of HbA2 with the TOSOH HLC-723G7 analyzer and the HELENA Beta-Thal Quik column kitClinical Biochemistry, 2006
- α‐Thalassemia: Hb H Disease and Hb Barts Hydrops FetalisAnnals of the New York Academy of Sciences, 2005